Medical Science Liaison
Mirum Pharmaceuticals
Medical Science Liaison
Mirum Pharmaceuticals
ASBT inhibitors for rare liver diseases
MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
The Medical Science Liaison (MSL) is a field-based Medical Affairs professional who is primarily responsible for establishing and maintaining relationships with thought leaders and other healthcare professionals (HCPs) as well as engaging in scientific exchange in their assigned territory. This individual will also serve as a scientific resource and scientific expert in the support of Mirum’s rare disease liver portfolio. This includes medical affairs and related activities such as medical congress staffing, advisory boards and cross-collaborative initiatives.
****We are looking for someone living in the New England area. Field Medical territory includes: Massachusetts, Maine, Vermont, New Hampshire, Connecticut, Rhode Island, and upstate New York (not including NYC) . No relocation will be offered for this role.****
JOB FUNCTIONS/RESPONSIBILITIES
QUALIFICATIONS
Education/Experience:
Knowledge, Skills and Abilities:
#LI-REMOTE
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
ASBT inhibitors for rare liver diseases
Mirum develops therapies for rare liver diseases, led by LIVMARLI (maralixibat), an oral ASBT inhibitor that reduces bile acid buildup and itching in Alagille syndrome and other cholestatic conditions. It is pursuing LIVMARLI for additional rare diseases such as PFIC and biliary atresia and developing volixibat for primary sclerosing cholangitis and primary biliary cholangitis. The company combines drug development with commercialization in the United States and other major markets, working with physicians, payers, and patient groups to improve access. Its goal is to bring effective therapies to patients with rare liver diseases and build a sustainable commercial presence in key markets.
Explore more opportunities at Mirum Pharmaceuticals